Back to search

Article

Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stress

2022-11-01

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Sodium-glucose cotransporter 2 inhibitors (SGLT2i) provide added vascular protection beyond glucose lowering to patients with type 2 diabetes mellitus (T2DM). Endothelial progenitor cells (EPCs) are an important endogenous repair mechanism for diabetic vascular complications. Yet, whether SGLT2i protect vessels in diabetic patients by improving the function o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dea277fe-9444-5809-b8dc-b10de414c187
DOI
10.21203/rs.3.rs-694662/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stressDOI 10.21203/rs.3.rs-694662/v2
Select a neighboring publication to make it the new centre.